首页> 美国卫生研究院文献>Case Reports in Womens Health >Did a shared thioredoxin-reductase gene mutation lead to maternal peripartum cardiomyopathy and fatal dilated cardiomyopathy in her son? A case report
【2h】

Did a shared thioredoxin-reductase gene mutation lead to maternal peripartum cardiomyopathy and fatal dilated cardiomyopathy in her son? A case report

机译:共有的硫氧还蛋白还原酶基因突变导致她儿子的产妇围产期心肌病和致命性扩张型心肌病吗?病例报告

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Peripartum cardiomyopathy (PPCM) is characterized by development of left ventricular systolic dysfunction and heart failure that occurs towards the end of pregnancy or in the postpartum period in the absence of structural heart disease. A complex interplay of pathophysiological mechanisms likely contributes to the PPCM phenotype. Mutations in the mitochondrial thioredoxin reductase gene (TXNRD2) have been identified as a cause of dilated cardiomyopathy. We report a case of a shared, inherited genetic mutation in the TXNRD2 gene in a mother with PPCM and her infant son who died of dilated cardiomyopathy.
机译:围产期心肌病(PPCM)的特征是左室收缩功能障碍和心力衰竭的发展,这种情况发生在妊娠末期或产后无结构性心脏病的情况下。病理生理机制的复杂相互作用可能有助于PPCM表型。线粒体硫氧还蛋白还原酶基因(TXNRD2)中的突变已被确定为扩张型心肌病的病因。我们报道了一例在母亲患有PPCM的婴儿儿子和死于扩张型心肌病的TXNRD2基因中共享,遗传遗传突变的案例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号